Germany's Bayer to buy US gene therapy specialist AskBio

BERLIN (AP) — German health care company Bayer said Monday it is buying Asklepios BioPharmaceutical, a U.S.-based firm specializing in gene therapy, in a deal worth up to $4 billion.

Become a Subscriber!

You have read all of your free articles this month. Select a plan below to start your subscription today.

Already a subscriber? Login

Sign In

Print & Digital

Includes home delivery and FREE digital access when you sign up with EZ Pay

• $16.25 per month

Buy

Unlimited Digital Access

*Access via computer, tablet, or mobile device

• $9.95 per month

Buy

Click here for more options